Replimune (REPL) has announced that it has no other option but to reduce its workforce and scale back U.S. manufacturing operations after the FDA on Friday declined to approve its lead asset, RP1, ...
News is breaking today that Replimune Group, Inc.'s (REPL) Biologics License Application ("BLA") requesting approval for its drug candidate RP1 (vusolimogene oderparepvec) in the indication of anti-PD ...
Please, please PLEASE don't use this to abuse repl.it or your school/workplace's filter! This is just a fun project I threw together with some neat features from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results